Patents by Inventor Katyna Borroto-Esoda

Katyna Borroto-Esoda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050113321
    Abstract: It has been unexpectedly found that a drug resistant strain of HIV exhibits the behavior of drug-naïve virus when given the combination of a ?-D-1,3-dioxolanyl nucleoside and an IMPDH inhibitor. In one nonlimiting embodiment, the HIV strain is resistant to a ?-D-1,3-dioxolanyl nucleoside.
    Type: Application
    Filed: October 21, 2004
    Publication date: May 26, 2005
    Inventors: Philip Furman, Katyna Borroto-Esoda
  • Publication number: 20020173491
    Abstract: It has been unexpectedly found that a drug resistant strain of HIV exhibits the behavior of drug-naïve virus when given the combination of a &bgr;-D-1,3-dioxolanyl nucleoside and an IMPDH inhibitor. In one nonlimiting embodiment, the HIV strain is resistant to a &bgr;-D-1,3-dioxolanyl nucleoside.
    Type: Application
    Filed: December 17, 2001
    Publication date: November 21, 2002
    Inventors: Philip A. Furman, Katyna Borroto-Esoda
  • Patent number: 6410546
    Abstract: Use of MKC-442 in combination with other antiviral agents for the treatment of patients infected with HIV is disclosed.
    Type: Grant
    Filed: April 7, 1998
    Date of Patent: June 25, 2002
    Assignee: Triangle Pharmaceuticals, Inc.
    Inventors: Phillip A. Furman, Cary P. Moxham, David W. Barry, Katyna Borroto-Esoda
  • Publication number: 20020002166
    Abstract: Use of MKC-442 in combination with other antiviral agents for the treatment of patients infected with HIV is disclosed.
    Type: Application
    Filed: August 14, 2001
    Publication date: January 3, 2002
    Inventors: Phillip A. Furman, Cary P. Moxham, David W. Barry, Katyna Borroto-Esoda